Mezzion Pharma Co.,Ltd.

Informe acción KOSDAQ:A140410

Capitalización de mercado: ₩931.6b

Mezzion PharmaLtd Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Dean Park

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO6.4%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Revenues Not Telling The Story For Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)

Jun 11
Revenues Not Telling The Story For Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)

Optimistic Investors Push Mezzion Pharma Co.,Ltd. (KOSDAQ:140410) Shares Up 26% But Growth Is Lacking

Mar 04
Optimistic Investors Push Mezzion Pharma Co.,Ltd. (KOSDAQ:140410) Shares Up 26% But Growth Is Lacking

We Might See A Profit From Mezzion Pharma Co.,Ltd. (KOSDAQ:140410) Soon

Feb 05
We Might See A Profit From Mezzion Pharma Co.,Ltd. (KOSDAQ:140410) Soon

Mezzion PharmaLtd (KOSDAQ:140410) Shareholders Have Enjoyed A Whopping 605% Share Price Gain

Dec 14
Mezzion PharmaLtd (KOSDAQ:140410) Shareholders Have Enjoyed A Whopping 605% Share Price Gain

CEO

Dean Park (68 yo)

no data

Permanencia

Mr. Dong Hyun Park, Dean is the Founder of Mezzion Pharma Co.,Ltd. (formerly known as Dong-A PharmTech Co. Ltd.) and also serves as its Chief Executive Officer and President. Mr. Park also founded and serv...